{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:02:33Z","timestamp":1783393353434,"version":"3.54.6"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Vietnam Grants for Cancer Research and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14719-3","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T08:42:46Z","timestamp":1754901766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Venous thromboembolism risk in newly diagnosed lymphoma patients: a real-world prospective observational study from Vietnam National Cancer Hospital"],"prefix":"10.1186","volume":"25","author":[{"given":"Thi Thu Huong","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyen Nga","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Yen","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Tung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Long","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van Quang","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"14719_CR1","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/S0049-3848(09)70137-9","volume":"123","author":"R Sud","year":"2009","unstructured":"Sud R, Khorana AA. Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model. Thromb Res. 2009;123:S18\u201321.","journal-title":"Thromb Res"},{"issue":"6","key":"14719_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1470-2045(05)70207-2","volume":"6","author":"P Prandoni","year":"2005","unstructured":"Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol. 2005;6(6):401\u201310.","journal-title":"Lancet Oncol"},{"issue":"1","key":"14719_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.amjmed.2005.06.058","volume":"119","author":"PD Stein","year":"2006","unstructured":"Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med. 2006;119(1):60\u20138.","journal-title":"Am J Med"},{"issue":"26","key":"14719_CR4","first-page":"5322","volume":"115","author":"V Caruso","year":"2010","unstructured":"Caruso V, Di Castelnuovo A, Meschengieser S, Lazzari MA, De Gaetano G, Storti S, Iacoviello L, Donati MB. Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events. Blood J Am Soc Hematol. 2010;115(26):5322\u20138.","journal-title":"Blood J Am Soc Hematol"},{"issue":"10","key":"14719_CR5","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1002\/cncr.23062","volume":"110","author":"AA Khorana","year":"2007","unstructured":"Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer: Interdisciplinary Int J Am Cancer Soc. 2007;110(10):2339\u201346.","journal-title":"Cancer: Interdisciplinary Int J Am Cancer Soc"},{"issue":"8","key":"14719_CR6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.clml.2020.02.021","volume":"20","author":"O Kirkizlar","year":"2020","unstructured":"Kirkizlar O, Kirkizlar TA, Umit EG, Asker I, Baysal M, Bas V, Gulsaran SK, Demirci U, Demir AM. The incidence of venous thromboembolism and impact on survival in hodgkin lymphoma. Clin Lymphoma Myeloma Leuk. 2020;20(8):542\u20137.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"14719_CR7","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/j.thromres.2018.01.028","volume":"164","author":"GH Lyman","year":"2018","unstructured":"Lyman GH, Culakova E, Poniewierski MS, Kuderer NM. Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer. Thromb Res. 2018;164:S112\u20138.","journal-title":"Thromb Res"},{"key":"14719_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.thromres.2016.05.008","volume":"143","author":"K Sanfilippo","year":"2016","unstructured":"Sanfilippo K, Wang T, Gage B, Luo S, Riedell P, Carson K. Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma. Thromb Res. 2016;143:86\u201390.","journal-title":"Thromb Res"},{"issue":"10","key":"14719_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.amjmed.2010.05.021","volume":"123","author":"X Zhou","year":"2010","unstructured":"Zhou X, Teegala S, Huen A, Ji Y, Fayad L, Hagemeister FB, Gladish G, Vadhan-Raj S. Incidence and risk factors of venous thromboembolic events in lymphoma. Am J Med. 2010;123(10):935\u201341.","journal-title":"Am J Med"},{"issue":"8","key":"14719_CR10","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1111\/jth.14824","volume":"18","author":"N van Es","year":"2020","unstructured":"van Es N, Ventresca M, Di Nisio M, Zhou Q, Noble S, Crowther M, Briel M, Garcia D, Lyman GH, Macbeth F. The Khorana score for prediction of venous thromboembolism in cancer patients: an individual patient data meta-analysis. J Thromb Haemost. 2020;18(8):1940\u201351.","journal-title":"J Thromb Haemost"},{"issue":"10","key":"14719_CR11","first-page":"4902","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood J Am Soc Hematol. 2008;111(10):4902\u20137.","journal-title":"Blood J Am Soc Hematol"},{"issue":"3","key":"14719_CR12","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1200\/JOP.2015.004473","volume":"11","author":"GH Lyman","year":"2015","unstructured":"Lyman GH, Bohlke K, Falanga A. Venous thromboembolism prophylaxis and treatment in patients with cancer: American society of clinical oncology clinical practice guideline update. J Oncol Pract. 2015;11(3):e442\u20134.","journal-title":"J Oncol Pract"},{"issue":"7","key":"14719_CR13","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","volume":"23","author":"D Farge","year":"2022","unstructured":"Farge D, Frere C, Connors JM, Khorana AA, Kakkar A, Ay C, Mu\u00f1oz A, Brenner B, Prata PH, Brilhante D. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol. 2022;23(7):e334\u201347.","journal-title":"Lancet Oncol"},{"issue":"5","key":"14719_CR14","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1200\/JCO.19.01461","volume":"38","author":"NS Key","year":"2020","unstructured":"Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AY, Arcelus JI, Wong SL, Balaban EP, Flowers CR, Francis CW. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2020;38(5):496\u2013520.","journal-title":"J Clin Oncol"},{"issue":"7","key":"14719_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.6004\/jnccn.2024.0046","volume":"22","author":"MB Streiff","year":"2024","unstructured":"Streiff MB, Holmstrom B, Angelini D, Ashrani A, Buckner T, Diep R, Fertrin KY, Fogerty AE, Crestani NG, Gangaraju R. Cancer-associated venous thromboembolic disease, version 2.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2024;22(7):483\u2013506.","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"14719_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.7570\/jomes23031","volume":"32","author":"J-H Haam","year":"2023","unstructured":"Haam J-H, Kim BT, Kim EM, Kwon H, Kang J-H, Park JH, Kim K-K, Rhee SY, Kim Y-H, Lee KY. Diagnosis of obesity: 2022 update of clinical practice guidelines for obesity by the Korean society for the study of obesity. J Obes Metabolic Syndrome. 2023;32(2):121.","journal-title":"J Obes Metabolic Syndrome"},{"issue":"3","key":"14719_CR17","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.thromres.2012.03.019","volume":"130","author":"LC Park","year":"2012","unstructured":"Park LC, Woo S-y, Kim S, Jeon H, Ko YH, Kim SJ, Kim WS. Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: results from a prospective cohort study with Asian population. Thromb Res. 2012;130(3):e6\u201312.","journal-title":"Thromb Res"},{"issue":"8","key":"14719_CR18","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/sj.bjc.6602504","volume":"92","author":"M Mohren","year":"2005","unstructured":"Mohren M, Markmann I, Jentsch-Ullrich K, Koenigsmann M, Lutze G, Franke A. Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis. Br J Cancer. 2005;92(8):1349\u201351.","journal-title":"Br J Cancer"},{"issue":"5","key":"14719_CR19","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.thromres.2015.09.001","volume":"136","author":"JL Lund","year":"2015","unstructured":"Lund JL, \u00d8stg\u00e5rd LS, Prandoni P, S\u00f8rensen HT, de Nully Brown P. Incidence, determinants and the transient impact of cancer treatments on venous thromboembolism risk among lymphoma patients in Denmark. Thromb Res. 2015;136(5):917\u201323.","journal-title":"Thromb Res"},{"issue":"1","key":"14719_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.thromres.2011.09.022","volume":"130","author":"K Yokoyama","year":"2012","unstructured":"Yokoyama K, Murata M, Ikeda Y, Okamoto S. Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large b-cell lymphoma. Thromb Res. 2012;130(1):7\u201311.","journal-title":"Thromb Res"},{"issue":"6","key":"14719_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41408-018-0096-1","volume":"8","author":"S Hohaus","year":"2018","unstructured":"Hohaus S, Tisi MC, Bartolomei F, Cuccaro A, Maiolo E, Alma E, D\u2019Al\u00f2 F, Bellesi S, Rossi E, De Stefano V. Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization. Blood Cancer J. 2018;8(6):54.","journal-title":"Blood Cancer J"},{"issue":"12","key":"14719_CR22","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1182\/bloodadvances.2018016683","volume":"2","author":"S Yamshon","year":"2018","unstructured":"Yamshon S, Christos PJ, Demetres M, Hammad H, Leonard JP, Ruan J. Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysis. Blood Adv. 2018;2(12):1429\u201338.","journal-title":"Blood Adv"},{"key":"14719_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-017-1065-4","volume":"35","author":"J Rupa-Matysek","year":"2018","unstructured":"Rupa-Matysek J, Gil L, Ka\u017amierczak M, Bara\u0144ska M, Komarnicki M. Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana risk score. Med Oncol. 2018;35:1\u20138.","journal-title":"Med Oncol"},{"issue":"10","key":"14719_CR24","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/ajh.24466","volume":"91","author":"D Antic","year":"2016","unstructured":"Antic D, Milic N, Nikolovski S, Todorovic M, Bila J, Djurdjevic P, Andjelic B, Djurasinovic V, Sretenovic A, Vukovic V. Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients. Am J Hematol. 2016;91(10):1014\u20139.","journal-title":"Am J Hematol"},{"issue":"7","key":"14719_CR25","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1002\/cam4.1540","volume":"7","author":"J Rupa-Matysek","year":"2018","unstructured":"Rupa-Matysek J, Brze\u017aniakiewicz\u2010Janus K, Gil L, Krasi\u0144ski Z, Komarnicki M. Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice. Cancer Med. 2018;7(7):2868\u201375.","journal-title":"Cancer Med"},{"key":"14719_CR26","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/S0049-3848(14)50004-7","volume":"133","author":"A Mahajan","year":"2014","unstructured":"Mahajan A, Wun T, Chew H, White RH. Lymphoma and venous thromboembolism: influence on mortality. Thromb Res. 2014;133:S23\u20138.","journal-title":"Thromb Res"},{"issue":"6","key":"14719_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.thromres.2010.08.017","volume":"126","author":"D Lekovic","year":"2010","unstructured":"Lekovic D, Miljic P, Mihaljevic B. Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma. Thromb Res. 2010;126(6):477\u201380.","journal-title":"Thromb Res"},{"key":"14719_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1182\/blood-2020-141367","volume":"136","author":"D Antic","year":"2020","unstructured":"Antic D, Otasevic V, Borchmann S, Muller H, Vukovic V, Djurasinovic V, Tomic K, Mihaljevic B, Gerotziafas G, Engert A. Throly score successfully classifies hodgkin lymphoma patients at risk of thromboembolic complication. Blood. 2020;136:8.","journal-title":"Blood"},{"issue":"7","key":"14719_CR29","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1002\/cam4.1540","volume":"7","author":"J Rupa-Matysek","year":"2018","unstructured":"Rupa-Matysek J, Brze\u017aniakiewicz-Janus K, Gil L, Krasi\u0144ski Z, Komarnicki M. Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice. Cancer Med. 2018;7(7):2868\u201375.","journal-title":"Cancer Med"},{"key":"14719_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.thromres.2018.01.037","volume":"163","author":"BT Samuelson Bannow","year":"2018","unstructured":"Samuelson Bannow BT, Konkle BA. Laboratory biomarkers for venous thromboembolism risk in patients with hematologic malignancies: A review. Thromb Res. 2018;163:138\u201345.","journal-title":"Thromb Res"},{"key":"14719_CR31","doi-asserted-by":"publisher","first-page":"901887","DOI":"10.3389\/fphar.2022.901887","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Lei H, Wang W, Zhu J, Zeng C, Lu Z, Li L, Li D, Long B, Liu H. Characteristics and predictors of venous thromboembolism among lymphoma patients undergoing chemotherapy: A cohort study in China. Front Pharmacol. 2022;13:901887.","journal-title":"Front Pharmacol"},{"issue":"6","key":"14719_CR32","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.3324\/haematol.2018.211466","volume":"104","author":"A Qdaisat","year":"2019","unstructured":"Qdaisat A, Soud RA, Wu CC, Rojas Hernandez CM, Li J, Meng QH, Abdel-Razeq H, Yeung SJ. Poor performance of D-dimer in excluding venous thromboembolism among patients with lymphoma and leukemia. Haematologica. 2019;104(6):e265\u20138.","journal-title":"Haematologica"},{"issue":"5","key":"14719_CR33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","volume":"34","author":"A Falanga","year":"2023","unstructured":"Falanga A, Ay C, Di Nisio M, Gerotziafas G, Jara-Palomares L, Langer F, Lecumberri R, Mandala M, Maraveyas A, Pabinger I, et al. Venous thromboembolism in cancer patients: ESMO clinical practice guideline. Ann Oncol. 2023;34(5):452\u201367.","journal-title":"Ann Oncol"},{"issue":"1","key":"14719_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","volume":"8","author":"AA Khorana","year":"2022","unstructured":"Khorana AA, Mackman N, Falanga A, Pabinger I, Noble S, Ageno W, Moik F, Lee AY. Cancer-associated venous thromboembolism. Nat Reviews Disease Primers. 2022;8(1):11.","journal-title":"Nat Reviews Disease Primers"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14719-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14719-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14719-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T22:56:33Z","timestamp":1757372193000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14719-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14719"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14719-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Vietnam National Cancer Hospital under decision number 108\/Q\u0110-VNC. Written informed consent was obtained in all patients. The studies are being conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1301"}}